Article
Advanced prostate cancer – patient survival and potential impact of enzalutamide and other…
Therapeutics and Clinical Risk Management · 2014 · Patel NK, Finianos A, Whitaker KD, Aragon-Ching JB
Key facts
| Title | Advanced prostate cancer – patient survival and potential impact of enzalutamide and other emerging therapies |
|---|---|
| First author | Patel NK, Finianos A, Whitaker KD, Aragon-Ching JB |
| Journal | Therapeutics and Clinical Risk Management |
| Published | Aug 16, 2014 |
| DOI | 10.2147/TCRM.S57509 |
| Devices mentioned | 210686, K994221 |
| Product codes mentioned | FGN, GEN, HXD, LRY, LTJ |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1